These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15950537

  • 1. 2n-fatty acids from phosphatidylcholine label sphingolipids--a novel role of phospholipase A2?
    Meyer SG, Karow W, de Groot H.
    Biochim Biophys Acta; 2005 Jun 15; 1735(1):68-78. PubMed ID: 15950537
    [Abstract] [Full Text] [Related]

  • 2. [14C]serine from phosphatidylserine labels ceramide and sphingomyelin in L929 cells: evidence for a new metabolic relationship between glycerophospholipids and sphingolipids.
    Meyer SG, de Groot H.
    Arch Biochem Biophys; 2003 Feb 01; 410(1):107-11. PubMed ID: 12559982
    [Abstract] [Full Text] [Related]

  • 3. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
    Holopainen JM, Subramanian M, Kinnunen PK.
    Biochemistry; 1998 Dec 15; 37(50):17562-70. PubMed ID: 9860872
    [Abstract] [Full Text] [Related]

  • 4. Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.
    Subbaiah PV, Horvath P, Achar SB.
    Biochemistry; 2006 Apr 18; 45(15):5029-38. PubMed ID: 16605271
    [Abstract] [Full Text] [Related]

  • 5. Role of sphingomyelin and ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2.
    Singh DK, Gesquiere LR, Subbaiah PV.
    Arch Biochem Biophys; 2007 Mar 15; 459(2):280-7. PubMed ID: 17178097
    [Abstract] [Full Text] [Related]

  • 6. Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids.
    Singh DK, Subbaiah PV.
    J Lipid Res; 2007 Mar 15; 48(3):683-92. PubMed ID: 17148553
    [Abstract] [Full Text] [Related]

  • 7. Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in immortalized astrocytes (DITNC).
    Tong W, Shah D, Xu J, Diehl JA, Hans A, Hannink M, Sun GY.
    J Mol Neurosci; 1999 Apr 15; 12(2):89-99. PubMed ID: 10527453
    [Abstract] [Full Text] [Related]

  • 8. Ceramides increase the activity of the secretory phospholipase A2 and alter its fatty acid specificity.
    Koumanov KS, Momchilova AB, Quinn PJ, Wolf C.
    Biochem J; 2002 Apr 01; 363(Pt 1):45-51. PubMed ID: 11903045
    [Abstract] [Full Text] [Related]

  • 9. Divergent fate of unsaturated and saturated ceramides and sphingomyelins in rat liver and cells in culture.
    Stein O, Oette K, Hollander G, Dabach Y, Ben-Naim M, Stein Y.
    Biochim Biophys Acta; 1989 Jun 08; 1003(2):175-82. PubMed ID: 2730890
    [Abstract] [Full Text] [Related]

  • 10. Ceramide accumulation during oxidant renal tubular injury: mechanisms and potential consequences.
    Zager RA, Conrad DS, Burkhart K.
    J Am Soc Nephrol; 1998 Sep 08; 9(9):1670-80. PubMed ID: 9727376
    [Abstract] [Full Text] [Related]

  • 11. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver.
    Babenko NA.
    Med Sci Monit; 2005 May 08; 11(5):BR131-138. PubMed ID: 15874883
    [Abstract] [Full Text] [Related]

  • 12. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q, Suzuki H, Sharma N, Sharma RP.
    Toxicol Sci; 2006 Dec 08; 94(2):388-97. PubMed ID: 16960033
    [Abstract] [Full Text] [Related]

  • 13. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide.
    Latorre E, Collado MP, Fernández I, Aragonés MD, Catalán RE.
    Eur J Biochem; 2003 Jan 08; 270(1):36-46. PubMed ID: 12492473
    [Abstract] [Full Text] [Related]

  • 14. Lipid metabolic changes caused by short-chain ceramides and the connection with apoptosis.
    Allan D.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):603-10. PubMed ID: 10642519
    [Abstract] [Full Text] [Related]

  • 15. Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells.
    Cao LC, Honeyman T, Jonassen J, Scheid C.
    Kidney Int; 2000 Jun 01; 57(6):2403-11. PubMed ID: 10844609
    [Abstract] [Full Text] [Related]

  • 16. Metabolic turnover of fatty acids and acylglycerols in rat sciatic nerve.
    Yao JK.
    J Neurochem; 1985 Aug 01; 45(2):589-95. PubMed ID: 4009176
    [Abstract] [Full Text] [Related]

  • 17. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency?
    Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K, Tsuchiya T, Kawainami S, Imokawa G.
    J Invest Dermatol; 1996 Jun 01; 106(6):1242-9. PubMed ID: 8752664
    [Abstract] [Full Text] [Related]

  • 18. In vivo metabolism of ceramides in rat brain. Fatty acid replacement and esterification of ceramide.
    Okabe H, Kishimoto Y.
    J Biol Chem; 1977 Oct 25; 252(20):7068-73. PubMed ID: 903352
    [Abstract] [Full Text] [Related]

  • 19. Effects of Chamomilla recutita flavonoids on age-related liver sphingolipid turnover in rats.
    Babenko NA, Shakhova EG.
    Exp Gerontol; 2006 Jan 25; 41(1):32-9. PubMed ID: 16183236
    [Abstract] [Full Text] [Related]

  • 20. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells.
    Venkataraman K, Riebeling C, Bodennec J, Riezman H, Allegood JC, Sullards MC, Merrill AH, Futerman AH.
    J Biol Chem; 2002 Sep 20; 277(38):35642-9. PubMed ID: 12105227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.